Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07207239

Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Semmelweis University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary aim of the study is to find the combination of neuroimaging-related markers, demographics, and clinical characteristics that predict the response of patients with therapy-resistant depression to theta-burst rTMS treatment. The secondary aim is to monitor the cognitive effects of TMS therapy.

Conditions

Interventions

TypeNameDescription
DEVICErepetative Transcranial Magnetic Stimulation (rTMS), theta-burst protocolTheta-burst rTMS treatment stimulates the left Dorsolateral Prefrontal Cortex (DLPFC). The TBS parameters the investigators adopted follows the standard TBS protocols, with 3-pulse 50-Hz bursts given every 200 ms (at 5 Hz) and an intensity of 100% active motor threshold. The investigators plan to deliver 1800 stimuli to the left DLPFC daily in 9.5-minute blocks for four weeks.

Timeline

Start date
2025-06-13
Primary completion
2028-06-13
Completion
2028-06-13
First posted
2025-10-03
Last updated
2025-10-03

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT07207239. Inclusion in this directory is not an endorsement.